Current Investment Opportunities for Investors and Financiers
May - August 2012
Replicon Corporate Finance is pleased to announce following private equity investment opportunities for relevant investors, Business Angels and Industrial or Commercial Players and financiers.
Below please find a list and limited description of our current offerings. Due to confidentiality reasons Replicon doesnât publish the names of our clients in this context. We are happy to provide more material on these private equity offerings, if you so wish.
Sector / Description | Size of the M&A or Financing | Phase |
Logistics |
Equity 1.0-2.0 M euro, Debt 4 M euro |
Expansion |
Real Estate |
EQUITY 1.0-3.0M euro, DEBT 3 M euro |
Construction |
Health /Food Supplement |
IPR sale or 100 000 euro EQUITY for complementing R&D |
Commercialization |
Cloth Design / Brand |
EQUITY 900 000 euro |
Int. Expansion |
NOTES: Experienced growth investors, investor groups and private individuals can also participate.
Additional information:
Logistics: minimum size of investment 100 000 euro; indicative interest preferably before Mid Summer; targeted closing of the financing in August / September.
Real Estate: minimum size of investment 30 000 euro; indicative interest preferably by 15th of June; targeted closing of the financing in June, roughly 2.0 M euro has been subscribed already.
Cloth Design / Brand: minimum size of investment 400 -900 000 euro, also crowd funding possible.
Sector know-how will be preferred.
Health/ Food Supplement: minimum size of investment 100 000 euro, indicative interest during summer 2012.
The above list represents situation in May 2012. It is non-exhaustive and naturally evolves over time.
For further information on above offerings, please contact:
Petteri Hirvonen, CEO, Senior Partner
+358 50 552 9633 (direct)
petteri.hirvonen (at) replicon.fi
Jouko Ahvenainen, Senior Partner,
+44 7889833165 (direct)
jouko.ahvenainen (at) replicongroup.com
About Replicon
Replicon Group is an independent financial and business adviser for growth companies and growth investors. Replicon provides financing and M&A solutions and related strategic advisory that facilitate business activities, efficiency, and increase profitability of corporations and other organizations.
Ajakohtaista (embedded) UK
-
12-04-2017 All Resources in Replicon Health Ltd.
-
31-03-2016 Innovative Expansion and Financing Strategy
-
04-08-2015 Service Offering: “Acid tests” for Life Science Sector Investment Strategies and Investments
-
03-03-2015 Growth Based on Innovative and Appealing Products
-
01-04-2014 Replicon Gains Accreditation for Two Useful Client Programs
-
07-10-2013 Replicon Evaluates Production Methods for Unique Food Supplement
-
06-03-2013 Replicon Initiates Industrial Licensing Project
-
01-03-2013 Learning Points from Nalmefene / Selincro
-
25-10-2012 Comparing Economics of Wind Power Alternatives
-
13-08-2012 OS/G Advertising and Marketing Agengy Ezpa Merge
-
09-05-2012 Current Investment Opportunities for Investors and Financiers
-
20-02-2012 - Replicon Compiles Business Strategy and Financing Plan for 6 M€ Wellness Concept
-
31-08-2011 - Replicon Valuation Analyses Enhances M&A